These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7255768)

  • 21. Vasopressin analgesia: specificity of action and non-opioid effects.
    Kordower JH; Bodnar RJ
    Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of aversive stimulus properties of vasopressin.
    Bluthé RM; Dantzer R; Mormède P; Le Moal M
    Psychopharmacology (Berl); 1985; 87(2):238-41. PubMed ID: 3931152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Facilitation of arginine-vasopressin analogs on learning and memory in rats].
    Liu RY; Lin C; Du YC
    Zhongguo Yao Li Xue Bao; 1990 Mar; 11(2):97-100. PubMed ID: 2275398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arginine vasopressin-induced sensitization in brain: facilitated inositol phosphate production without changes in receptor number.
    Poulin P; Pittman QJ
    J Neuroendocrinol; 1993 Feb; 5(1):23-31. PubMed ID: 8485541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of vasopressin analog: [d(CH2)(1)5,Tyr(Me)2,delta 3Pro7]AVP on learning and memory processes in rats with experimental amnesia.
    Car H; Borawska M; Wiśniewski K
    Pol J Pharmacol; 1993; 45(1):11-22. PubMed ID: 8401755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.
    Arnauld E; Bibene V; Meynard J; Rodriguez F; Vincent JD
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R674-84. PubMed ID: 2923256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate social recognition in rat.
    Bluthé RM; Dantzer R
    Brain Res; 1992 Feb; 572(1-2):261-4. PubMed ID: 1611520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of vasopressin analogue [d(CH2)5(1),Tyr(Me)2]AVP on memory process in rats with experimental amnesia.
    Car H; Borawska M; Wiśniewski K
    Acta Neurobiol Exp (Wars); 1995; 55(3):207-11. PubMed ID: 8553914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin.
    Kovács GL; Liu B; Burbach JP; Van Ree JM; De Wied D
    Eur J Pharmacol; 1989 Feb; 161(1):27-35. PubMed ID: 2721547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ACTH and vasopressin on extinction: evidence of opiate mediation.
    DeVito WJ; Brush FR
    Behav Neurosci; 1984 Feb; 98(1):59-71. PubMed ID: 6320844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs.
    Liard JF; Spadone JC
    J Cardiovasc Pharmacol; 1984; 6(4):713-9. PubMed ID: 6206331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The vasopressin receptor antagonist dPTyr (Me) AVP does not prevent stress-induced ACTH and corticosterone release.
    Mormède P
    Nature; 1983 Mar 24-30; 302(5906):345-6. PubMed ID: 6300679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
    Kovács GL; De Wied D
    Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive avoidance behavior, vasopressin and the immune system. A link between avoidance latency and immune response.
    Croiset G; Heijnen CJ; de Wied D
    Neuroendocrinology; 1990 Feb; 51(2):156-61. PubMed ID: 2106096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central infusion of vasopressin in male rats accelerates extinction of conditioned taste avoidance induced by LiCl.
    Hayes UL; Chambers KC
    Brain Res Bull; 2002 Mar; 57(5):727-33. PubMed ID: 11927378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.